Internal Medicine

 

Ganga Hematillake, MD, MS, MS (Pharm), FACP

Assistant Clinical Professor of Medicine

Staff Physician, VACCHCS
 

 

 

 

 

 

 

 

 

 

 

 

  Medical School: St. George’s University School of Medicine (MD)
Idaho State University, College of Pharmacy
Idaho State University, College of GS and Research
North Colombo Medical College, Sri Lanka (MBBS)
  Board Certified:

Internal Medicine

  Awards and Recognition: VA Stars and Stripes Excellence Award
Outstanding Graduate Student Research Project
VHA Special Contributions Award
  Publications:

Cardiovascular toxicity associated with intravenous administration of Boronophenylanine formulations. T.R. LaHann, C. Cills, M.G. Hematillake, in Advances in Neutron Capture Therapy (p513 – p517), Plenum Press, New York, 1993. Presented at Fifth International Symposium on Neutron Capture Therapy, 1992, in Atlanta Georgia.

 

Abstracts:

 

  1. The role of Electronic Medical Records (EMR) innovations in identifying Chronic Heart Failure (CHF) self care knowledge gaps: A nursing assessment tool to customize patient education at point of care. Ganga Hematillake, MD, MS, MS (Pharm), Prakash Deedwania, MD, Sean McFarland, RN, MS, Alan Cohen, MD, Jian Huang, MD, Rebekah Carlson, RN,MSN, Julie Evans, BA and Goebel Paul, MD.- Journal of Cardiac Failure - August 2010 (Vol. 16, Issue 8, Supplement, Page S101). Presented at the 14th Annual Scientific Meeting of the Heart Failure Society of America, San Diego, California September 12-15, 2010


Chronic Medical Conditions and Psychiatry Disorders in Male Patients with Erectile Dysfunction in a VA Population. Jian Huang, MD, Wei Gu, MD, Sean McFarland, MS, Jocelyn Fong, MD, Ronna Mallios, MS, Ganga Hematillake, MD, Vishal Pall, MD, Alan Cohen, MD. J Gen Intern Med, April 2010  

 

Lower BMI and Diabetes are associated with increased hospitalization and all cause mortality in elderly heart failure patients.  M. Ganga Hematillake, Sean McFarland, Prakash Deedwania, Julie Evans, Ronna Mallios, Paul J Goebel, Alan Cohen, Jian Huang Journal of Investigative Medicine – volume 58 ,number 1 – January 2010 – page 168

 

Association Between Frequently Prescribed Medications And Bone Density In A Va Population M.G. Hematillake1; S. Mcfarland1; A. Ikonian1; J. Evans1; R. Mallios2; J. Huang1. 1VA Central California Health Care System, Fresno, CA; 2University of California, San Francisco, Fresno, CA. (Abstract Tracking ID # 204705) Society of General Internal Medicine, Annual Proceedings, 2009

 

The favorable effects of Alpha 1 Receptor blockers on Lipid profile in men  older than 55. J. Huang, V. Paul, W. Gu, R. Mallios, G. Twitchell, H Ganga, A. Cohen, Journal of Investigative Medicine, Volume 57,  Number 1 , January 2009

 

Fludarabine linked Coombs negative hemolysis associated with CLL and Mental Cell Lymphoma (MCL), Jasotha Sanmugaraja, Ganga Hematillake, Joel M. Schwartz, Gloria Fernandez. Abstract 452081 – Category 101, American Society of Hematology – 1999

 

Activation of Endothelin-A receptors in the ventral medulla causes cardiovascular collapse, (abstract # 244) M.G. Hematillake, FASEB Journal, April 1995. Presented at the Experimental Biology 95, April 9, 1995 in Atlanta, Georgia, USA

 

Cardiovascular toxicity associated with intravenous administration of Boronophenylanine formulations. T.R. LaHann, C. Cills, M.G. Hematillake, in Advances in Neutron Capture Therapy (p-513-p517), Plenum Press, New York, 1993. Presented at Fifth International Symposium on Neutron Capture Therapy 1992, in Atlanta, Georgia, USA

 

Anatomic pathway by which central application of Endothelin-1 (ET-1) reduces     cardiac output (abstract # 582), M.G.Hematillake, and T.R. LaHann, The FASEB Journal, volume 7, number 3, April 1993. Presented at the Experimental Biology 93, March 1993, New Orleans, Louisiana, USA

 

Central modulation of cardiac output by Endothelin - 1, (abstract # 3444), M.G. Hematillake and T.R. LaHann, The FASEB Journal, volume 6, number 4, Feb 1992. Presented at the FASEB (Federation of American Societies on Experimental Biology) International Conference, April 1992, Anaheim, California, USA

 

Physiological mechanism by which central application of Endothelin-1 reduces cardiac out put (abstract # 426.1) T.R. LaHann, M. G. Hematillake, G. Daniel, Society for Neuroscience Abstracts, 1992, Presented at the Annual meeting of the Society for Neuroscience, Oct. 1992, in Anaheim, California, USA

 

Endothelin -1 acting on the ventral surface of the cerebral medulla decreases cardiac stroke out put in rats. M.G. Hematillake, and T.R. LaHann, Presented at the Annual regional meeting of the Society for experimental Biology and Medicine, Oct. 1992, Missoula, Montana, USA

 

Neural tissue transplants and methyl prednisone to promote recovery from spinal cord injury in rats (abstract # Z8), M.G. Hematillake, and R. Spall, The Retort, volume 27, number 2, 1992. Presented at the 33rd annual conference of the Idaho Academy of Science, 1992

 

Active Research Projects:

 

Association of Chronic use of Medications and Osteoporosis/ Increased Fracture Risk: Do we have an Iatrogenic epidemic of osteoporosis in primary care? (Primary Investigator)

 

Effects of home self management and medication adherence evaluations by telemedicine interventions in chronic heart failure (CHF). (Primary Investigator)

 

Optimization of CHF management in VA:  Improve post discharge care planning and follow-up outpatient care management to prevent increase morbidity, re-hospitalization and decrease mortality. (Co-Primary Investigator)

 

Reserach Grants:

 

Effects of home self management and medication adherence evaluations by Telemedicine Interventions in Chronic Heart Failure (CHF). Research grant of $100,000 for 2010. Center for Technology and Aging of the SCAN Foundation - http://www.thescanfoundation.org/

 

Optimization of CHF management in VA:  Improve post discharge care planning and follow-up outpatient care management to prevent increase morbidity, re-hospitalization and decrease mortality. (Co-Primary Investigator)  - VA Health Services Research and Development (VAHSRD) Research Grant  - $70,000 for FY 2009